Background We aimed to systematically review the evidence on adverse mental health
outcomes in breast cancer survivors (≥ 1 year) compared with women with no history of …

Objective To investigate the effect of endocrine therapies on a wide range of specific clinical
cardiovascular disease outcomes in women with a history of non-metastatic breast cancer …

Learning Objectives After completing this course, the reader will be able to: Discuss the role
of steroid sulfatase in regulating estrogen production in postmenopausal women. Describe …

This position statement from the Heart Failure Association of the European Society of
Cardiology Cardio‐Oncology Study Group in collaboration with the International Cardio …

Background The past few decades have seen substantial improvements in cancer survival,
but concerns exist about long-term cardiovascular disease risk in survivors. Evidence is …

Purpose: Inhibition of steroid sulfatase (STS), the enzyme responsible for the hydrolysis of
steroid sulfates, represents a potential novel treatment for postmenopausal women with …

Purpose There is limited high-quality evidence on quality of life, anxiety, and depressive
symptoms in breast cancer survivors and women with no history of cancer. We aimed to …

Background People with active cancer are recognised as at risk of COVID-19 complications,
but it is unclear whether the much larger population of cancer survivors is at elevated risk …

Background Cancer survivors have a higher risk for developing cardiovascular diseases
than the general population. Objectives The aim of this study was to investigate whether …

Background Breast cancer is the most common cancer diagnosed in women globally, and 5-
year net survival probabilities in high-income countries are generally> 80%. A cancer …